- £1.28bn
- £1.45bn
- £1.49bn
- 95
- 68
- 84
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 930 | 929 | 1,233 | 1,396 | 1,488 |
Cost of Revenue | |||||
Gross Profit | 342 | 298 | 428 | 486 | 1,224 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 821 | 867 | 1,105 | 1,248 | 1,342 |
Operating Profit | 109 | 61.6 | 127 | 148 | 146 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 94.6 | 48.1 | 114 | 136 | 134 |
Provision for Income Taxes | |||||
Net Income After Taxes | 78 | 33.7 | 78.6 | 113 | 106 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 77.9 | 33.6 | 78.5 | 113 | 106 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 77.9 | 33.6 | 78.5 | 113 | 106 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.01 | 0.004 | 0.048 | 0.068 | 0.324 |
Dividends per Share |